PEVION BIOTECH AG has a total of 21 patent applications. Its first patent ever was published in 2006. It filed its patents most often in EPO (European Patent Office), Australia and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are EPIGENESIS PHARMACEUTICALS INC, CAR T SHANGHAI BIOTECHNOLOGY CO LTD and AMORCYTE INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | Australia | 3 | |
#3 | United States | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Canada | 2 | |
#6 | Republic of Korea | 2 | |
#7 | South Africa | 2 | |
#8 | China | 1 | |
#9 | EAPO (Eurasian Patent Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Kammer Andreas | 15 |
#2 | Zurbriggen Rinaldo | 15 |
#3 | Moser Christian | 14 |
#4 | Amacker Mario | 9 |
#5 | Rasi Silvia | 9 |
#6 | Westerfeld Nicole | 8 |
#7 | Grunwald Thomas | 2 |
#8 | Zurbriggen Rinaldo Dr | 1 |
#9 | Christian Moser | 1 |
#10 | Kammer Andreas Dr | 1 |
Publication | Filing date | Title |
---|---|---|
EP2039764A1 | Truncated secretory aspartyl proteinase 2 | |
EP2014279A1 | Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof | |
EP1938835A1 | Non-specific immunostimulating agents |